Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 4 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Yesterday
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.
Roshini Claire Anthony, 10 Jan 2018

Adding rifampicin to standard antibiotic therapy does not improve outcomes in individuals with Staphylococcus aureus (S. aureus) bacteraemia, the ARREST* trial shows. However, rifampicin may contribute towards a minor reduction in bacteraemia recurrence.

Ketorolac possesses analgesic potency against postoperative pain

05 Oct 2017

Ketorolac-based analgesics demonstrate substantial local infiltration during treatment of pain in patients who have undergone breast surgery, according to a study. Locally administered ketorolac substantially reduces postoperative pain, and the effect is better than local bupivacaine.

Researchers performed a systemic review and meta-analysis on the efficacy of locally administered ketorolac-based analgesics in managing pain after breast surgery. The main study outcome was pain level, measured using a visual analogue scale (VAS) at 1 and 6 hours following surgery.

Pooled data from four randomized controlled trials, involving 255 patients, showed that VAS pain scores at 1 hour postsurgery were significantly lower among patients administered a ketorolac solution (weighted mean difference [WMD], -2.04; 95 percent CI, -3.08 to -1.00) or ketorolac-bupivacaine solution (WMD, -2.30; -4.07 to -0.54) relative to controls.

At the 6-hour time point, VAS pain scores were markedly reduced with the ketorolac-bupivacaine solution than with controls (WMD, -1.40; -2.48 to -0.32). However, at 1 hour, the ketorolac solution was superior in efficacy compared with the bupivacaine solution (WMD, -1.70; -2.81 to -0.59).

Ketorolac was the first nonsteroidal anti-inflammatory drug to be approved in the US for intravenous (IV) use in the management of postoperative pain in both adults and children. In children, the drug is used in the postoperative setting for procedures such as general, otolaryngological, urological, cardiac, trauma and orthopaedic surgeries, as well as ophthalmology procedures, and chest tube placement and removal. [J Pain Res 2010;3:67-79; Anesthesiology 2015;122:150-71; Pediatr Ann 2014;43:e169-75]

Ketorolac can be administered orally or parenterally as either IV or intramuscular. The parenteral route of administration is preferable in the immediate postoperative period, as the gastrointestinal tract may be compromised as a consequence of postoperative ileus or due to increased predisposition to nausea and vomiting after receipt of anaesthetic drugs during surgery. [Cochrane Database Syst Rev 2017;doi:10.1002/14651858.CD012294]

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 4 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
Yesterday
The risk of stroke and subsequent mortality is significantly elevated in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), a recent study has shown.
Roshini Claire Anthony, 10 Jan 2018

Adding rifampicin to standard antibiotic therapy does not improve outcomes in individuals with Staphylococcus aureus (S. aureus) bacteraemia, the ARREST* trial shows. However, rifampicin may contribute towards a minor reduction in bacteraemia recurrence.